Table 1.
Baseline Demographic and Clinical Characteristics of AUTO-BENRA Study
| Demographics Characteristics | N Missed | |
|---|---|---|
| Age y, mean±SD | 57.31±9.97 | |
| Female, n (%) | 34 (62.96%) | |
| Educational level | ||
| High school n (%) | 9 (18.75%) | |
| Vocational training n (%) | 14 (29.17%) | |
| Secondary education n (%) | 17 (35.41%) | |
| Primary education n (%) | 8 (16.67%) | |
| BMI mean±SD | 28.04±4.62 | 1 |
| Current/ex- smoker >10p/year n (%) | 9 (16.7%) | |
| Comorbidities | ||
| GERD n (%) | 32 (59.26%) | |
| OSAS (%) | 5 (9.26%) | |
| Mental disorders n (%) | 13 (24.07%) | |
| Bronchiectasis n (%) | 11 (20.37%) | |
| Nasal polyps n (%) | 25 (26.3%) | |
| AERD n (%) | 16 (30.7%) | |
| Aeroallergen’s sensitization-atopy n (%) | 38 (70.37%) | |
| Biomarkers | ||
| Total IgE KU/L mean ±SD | 554.21±1337.22 | |
| Eosinophils Cells /microliter ±SD | 742.04±441.73 | |
| Clinical Characteristics | ||
| Prednisone-dependent patients n (%) | 24(44.4%) | |
| Severe exacerbation rate Exacerbations/year ±SD | ||
| FEV1 percentage mean ±SD | 68.82±15.92% | 2 |
| ACT points mean±SD | 14.10±4.41 | 2 |
| MiniAQLQ mean ±SD | 3.99±1.30 | 26 |
Abbreviations: BMI, body mass index; GERD, gastroesophageal reflux disease; OSAS, obstructive sleep apnea syndrome; AERD, aspirin-exacerbated respiratory disease; FEV1, forced expiratory volume in first second; ACT, asthma control test; MiniAQLQ, reduced version of asthma quality of life questionnaire.